Key result
Capecitabine plus bevacizumab achieved prolonged control of right ventricular cardiac metastasis from colorectal cancer in a 75-year-old woman unsuitable for surgical resection.
Why the study?
Right ventricular cardiac metastasis from colorectal cancer is rare, clinically silent, lacks standardized treatment, and has only twelve previously reported cases in the literature.
Does capecitabine plus bevacizumab control right ventricular cardiac metastasis from colorectal cancer?
Case Report (n=13)
Does capecitabine plus bevacizumab control right ventricular cardiac metastasis from colorectal cancer?
Answers are grounded in this paper and cite their sources.
Capecitabine plus bevacizumab may be an effective treatment strategy for controlling right ventricular cardiac metastasis from colorectal cancer, especially when surgical resection is high-risk due to coexisting metastases.
BACKGROUND/AIM: Right ventricular cardiac metastasis from colorectal cancer (CRC) is rare and clinically silent. There is no standardised treatment. To date, only twelve cases have been reported in the literature. This is a case report and literature review of right ventricular cardiac metastasis from CRC. CASE REPORT: A 75-year-old woman with a history of CRC treated with sigmoidectomy followed by liver and lung metastasectomy presented with a right ventricle tumour. Biopsy showed metastatic adenocarcinoma not suitable for resection because multiple lung metastases coexisted. The metastases were controlled for a prolonged duration by chemotherapy with capecitabine plus bevacizumab. According to the review of 13 cases, the median age of metastatic CRC that involves the right ventricle is 71 years and the primary site is half the colon and rectum. Half of cases have non-cardiac metastases at cardiac metastasis diagnosis. Chemotherapy is more suitable than resection in cases with metastases other than heart because resection of the right ventricle has a high risk. CONCLUSION: Cardiac right ventricular metastasis from CRC can be controlled by capecitabine plus bevacizumab.
No takes yet. Share an insight, caveat, or question.
Hiroi et al. (2020) conducted a case report in Right ventricular cardiac metastasis from colorectal cancer (n=13). Capecitabine plus bevacizumab was evaluated on Metastasis control. Capecitabine plus bevacizumab achieved prolonged control of right ventricular cardiac metastasis from colorectal cancer in a 75-year-old woman unsuitable for surgical resection.
Synapse has enriched 10 related papers. Consider them for comparative context: